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1 Introduction
Invasive candidal infections in the neonatal
period have been increasing steadily during the
past decade [3, 8, 12]. The increase of invasive
candidal infections in newborn infants can at least
in part be attributed to increased survival of pre-
mature infants as a result of technological ad-
vances in neonatal care [1]. Endocarditis is an un-
common complication of invasive candidiasis.
We will report the development of candidal endo-
carditis in a very low birth weight infant, even
after antifungal therapy had been administered.
2 Case report
This 780-g male infant was delivered vaginally in
an ambulance car at an unknown gestational age
to a 23-year-old mother. On arrival at the neona-
tal intensive care unit he required complete resus-
citation. Mechanical ventilation was started be-
cause of respiratory distress syndrome. An umbil-
ical arterial catheter was inserted to the level of
the diaphragm and remained in place for 8 days.
Besides a dopamine and dobutamine infusion,
ampicillin/sulbactam and netromycine were also
administered for 17 days.
A Grade III intracranial hemorrhage was detected
with a cranial ultrasound. Nose and throat cul-
tures were obtained on day 1 and Klebsiella and
coagulase negative Staphylococcus were isolated.
On day 8 the infant developed symptomatic pat-
ent ductus arteriosus, which required intravenous
indomethacin therapy. On the following day the
closure of the ductus arteriosus was documented
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by an echocardiograph. On day 12, he was extu-
bated but still required nasal CPAP therapy. On
day 18, the infant developed abdominal disten-
sion. The white blood cell count was 26 3 109/L,
while the platelet count was 87 3 109/L. The
CRP value was 56 mg/L. Echocardiography did
not show vegetation or any structural anomaly
except for patent foramen ovale at this time. Cul-
tures were obtained from nose, throat, stool and
cerebrospinal fluid. Cultures from blood were not
obtained because of technical difficulties. The
increase in the frequency of invasive candidal in-
fections had not been experienced in our depart-
ment previously. Owing to this, bacterial infec-
tion was suspected and the infant was treated with
ceftazidim until the results of the cultures arrived.
Candida albicans was isolated from each culture.
Parenteral fluconazol therapy was initiated on day
25 at a daily dose of 3 mg/kg. Five days later
repeated cultures remained sterile except for the
cerebrospinal fluid. Intravenous fluconazole ther-
apy was continued. On day 40 a loud systolic
murmur was detected. Echocardiography demon-
strated a 6 3 7 mm pedunculated mass in the left
atrium that prolapsed into the left ventricle (fig-
ure 1). Another mass was detected in the right
ventricular outflow tract spreading into the pul-
monary artery causing remarkable narrowing of
the pulmonary artery (figure 1). Surgical removal
of the vegetations was not recommended because
of the very low body weight and severe state of
the infant. Finally, the patient received higher
doses of fluconazole, but he deteriorated rapidly
and died on day 45.
During autopsy, we found both macroscopic and
microscopic features of immaturity. However, no
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morphologic signs of congenital malformations in
any of the major organs were found on the new-
born. The brain showed mild edema and hydro-
cephalus with posthemorrhagic and infarcted per-
iventricular lesions. Light microscopy showed,
that the alveolar spaces of the lungs had not been
A
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Figure 1. The transthoracic echocardiography: A 2 The four-chamber view, showing a large pedunculated mass
attached to the left atrial wall and prolapsing into the left ventricle (BK: left ventricle, BP: left atrium JP: right
atrium, JK: right ventricle). B 2 The parasternal short axis view: a fungal mass narrowing the right ventricular
outflow tract (JP: right atrium, JK: right ventricle, AO: aortic root, AP: pulmonary artery, VEG: vegetation).
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expanded completely and had contained eosino-
philic proteineous precipitates characteristic of
hyaline membrane disease. In addition, focally
massive intraalveolar and interstitial hemorrhages
with interstitial pneumonitis were also demon-
strable. In some of the pulmonary and cerebral
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vessels fungal and bacterial embolic colonies were
present indicating sepsis (figure 2). Furthermore,
the heart was found in a normal anatomic position
without signs of congenital heart defect. However,
bulky vegetations were present on the mitral valves
obscuring the valve leaflets. Accordingly, the en-
docardium and the subendocardial myocardium
showed fibrin-rich destructive inflammatory leu-
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Figure 2. A 2 Autopsy lung specimen: PAS staining reveals intravascular PAS-positive embolic colonies indicat-
ing fungal sepsis. B 2 Autopsy heart specimen: PAS staining reveals intracardiac fungal vegetation destroying
endocardium and spreading into the subendocardial myocardium.
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kocytic infiltrates that contained colonies of PAS-
positive Candida albicans (figure 2). There were
no signs of necrotizing enterocolitis.
3 Discussion
The frequency of candidal blood stream infec-
tions has increased by as much as 20-fold in some
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institutions [4]. Premature neonates hospitalised
in neonatal intensive care units are particularly
prone to infection by Candida species, espe-
cially albicans. Prolonged antibiotic therapy, in-
tubation, intravenous catheterization, parenteral
nutrition and corticoid therapy can all contribute
to this susceptibility [1, 3]. Lymphocytes from
premature infants, especially from male infants,
have reduced capacity to inhibit the growth of
C. albicans [14]. Phagocytosis of Candida albi-
cans by leukocytes in premature and mature
infants has been shown to be similar to phago-
cytosis in adults [17]. On the other hand the
cytotoxic activity of neonatal macrophages can-
not be fully activated by IFN-gamma [10]. The
increased survival and prolonged stay in inten-
sive care for small premature infants has re-
sulted in a higher workload for nurses, which
can lead to a breakdown in asepsis during child
handling [2]. This phenomenon has been de-
monstrated previously during bacterial infections
[5]. The increased need for neonatal beds and
personnel has not been accompanied by the re-
cruitment of more nurses and doctors during the
past few years in Hungary.
Prolonged treatment with antibiotics probably
played a role in the development of systemic fun-
gal infection in our patient.
We chose fluconazole for the treatment of sys-
temic candidiasis in order to avoid the toxic ef-
fects of amphotericin B and flucytosine. Flucona-
zole had only a transient effect and could not con-
trol the progression of the disease. Similar obser-
vations have been reported in candidemia occur-
ring in infants [8]. The development of Candida
endocarditis in a premature infant while being
treated with fluconazole had not previously been
reported. Candida endocarditis is a relatively rare
complication of invasive candidiasis, but it may
represent the tip of the iceberg concerning fungal
infections.
Most cases of fungal endocarditis in early infancy
are associated with central venous catheteriza-
tion. 17 premature infants have previously been
described with fungal endocarditis [11]. In 15
cases the use of a central venous catheter was
reported. In our patient an umbilical arterial cath-
eter was inserted for 8 days and thereafter the
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peripheral veins were cannulated. Although the
umbilical arterial catheter was removed ten days
before the symptoms appeared, it might have
been a contributing factor in the development of
the systemic fungal infection. No structural heart
anomalies were detected by echocardiography
and autopsy. Transient symptomatic ductus arteri-
osus was treated successfully with indomethacin.
Experimental work with animal models has de-
monstrated that damaged endocardium or pros-
thetic material can serve as foci for the localisa-
tion of candidal infection in fungal endocarditis
[9, 16]. In our case, none of the mentioned factors
were observed. It is very likely, vegetations can
develop without previous mechanic endothelial
damage.
Echocardiography is a valuable diagnostic tool
in the case of fungal endocarditis [6]. Echocar-
diography alone cannot distinguish infected
from noninfected lesions, but the clinical course,
persistent fungemia will confirm the diagnosis.
A combined medical and surgical approach is
required in the case of fungal endocarditis [6,
7, 15], although successful medical management
has also been reported [13, 18]. In critically ill
infants antifungal therapy without surgery may
be an option because of the high rates of peri-
operative mortality [13, 18]. In our case surgical
intervention was not applicable because of the
size and severe condition of the baby. Because
of the well-known nephrotoxicity of amphoteri-
cin, we preferred fluconazole treatment. The
question arises whether an exchange of flucona-
zole treatment into the amphotericin infusions
would have resulted in a favorable outcome.
Increased awareness of Candida endocarditis
should have prompted an earlier echocardio-
graphic investigation even if no cardiac symp-
toms had been present [6].
The aim of this report is to emphasize the high
risk of the development of fungal infections in
very low birth weight infants being treated with
antibiotics. As soon as clinical signs of infection
appear during or very shortly after a certain
period of antibacterial therapy, also systemic anti-
fungal treatment should be initiated immediately
after obtaining cultures. Furthermore, echocardio-
graphic evaluation during antifungal treatment
should be recommended.
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Abstract
Endocarditis is an uncommon complication of invasive
candidiasis. We present a fatal case of endocarditis
caused by Candida albicans in a very low birth weight
infant. The 780-g male infant did not have any struc-
tural heart disease and a central venous catheter was
not placed. Endocarditis developed in spite of parenteral
fluconazole treatment. Echocardiography was a valu-
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